Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

New Stock Coverage: Home Shop Till You Drop at HSN Inc.


Wall Street ratings agencies set the tone for today's stock market.

Whither the weather? Whether or not it was coincidental, Willard Scott turned 80 on jobs Friday, just as economists were left red-faced trying to explain why construction companies managed to add 15,000 jobs in a frigid February. (Meteorological-minded investors will hope 2014 is a repeat of 1996, a year than began in a blizzard and ended up with Alan Greenspan bemoaning "irrational exuberance" run amok in equities.) Surprisingly strong employment data sent the S&P 500 Index (INDEXSP:.INX) to a record as the Lehman debacle of 2008 descents ever more into the mists of ancient history. Even as frowns remain frozen -- where Eliot Spitzer once glowered, now it is Satoshi Nakamoto's time to turn that smile upside-down. (Having seen what happened to Mt. Gox this morning, who can blame him for feeling so glum?) Elsewhere, it was the most exciting week in elevators since Benicio and Scarlett supposedly spent some time in one. The alleged Bitcoin inventor was cornered in an Otis, even as Goldman Sachs (NYSE:GS) -- up a Dow (INDEXDJX:.DJI)-best 4.7% -- got a real lift from a book banishment. Actually, maybe the deal is not dead after all. A Mexican drug lord evidently finally is in a shootout, three years after he was prematurely killed off. You only live twice? Smith & Wesson (NASDAQ:SWHC) surged some 19.91% last week, so he picked a fine time to expire.
There aren't any top-tier economic reports released today, but FuelCell Energy (NASDAQ:FCEL), Full House Resorts (NASDAQ:FLL), and Urban Outfitters (NASDAQ:URBN) are all expected to announce earnings.
Amedica (NASDAQ:AMDA): Shares are begun with a Buy at Needham, whose price objective is $13. The company may increase its market share in the spine market, currently valued at $9 billion.
Cliffs Natural Resources (NYSE:CLF): Axiom Capital starts the struggling commodity company at a Sell.
Concert Pharmaceuticals (NASDAQ:CNCE): UBS starts the stock with a Buy opinion and $25 target price.
Eagle Pharmaceuticals (NASDAQ:EGRX): The company is covered with a Buy at Cantor Fitzgerald, whose target is $21.
Harman International (NYSE:HAR): Raymond James resumes Outperform-rated research.
HSN, Inc. (NASDAQ:HSNI): The owner of Home Shopping Network is begun with a Buy recommendation and $70 price objective at UBS.
Installed Building Products (NYSE:IBP): IBP is a new Buy ($20 target) at BB&T Capital Markets.
Liberty Interactive (NASDAQ:LINTA): UBS launches the company at a Buy.
National Bank of Greece (NYSE:NBG): NBG is a new Buy at Deutsche Bank, sending it higher ahead of the open.
North Atlantic Drilling (NYSE:NADL): Shares are assigned an Overweight by Barclays, whose objective is $11.
Seattle Genetics (NASDAQ:SGEN): H.C. Wainwright has a Buy, and $65 target, on the equity.
Talmer Bancorp (NASDAQ:TLMR): Shares are an Outperform at RBC Capital, which cites its prospects for solid loan growth.
See also:

Stock Downgrades: Will Staples Be the Bain of Mitt Romney?

Stock Upgrades: Lost an Hour of Sleep? Replenish Your Daylight Savings With DreamWorks
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos